In a groundbreaking moment in the food allergy world, Children’s Healthcare of Atlanta’s Dr. Brian Vickery administered the first-ever dose of a new FDA-approved peanut allergy oral immunotherapy treatment for pediatric patients in March 2020. Two months prior, the FDA had approved the new oral immunotherapy, Palforzia, to treat children ages 4 to 17 with peanut allergy – making it the first and only FDA-approved treatment for any food allergy. Ian Bicknell, a 13-year-old Children’s food allergy patient, was the first pediatric patient nationwide to receive the therapy.
